The correlation of LEDGF/p75 expression with these two proteins is of interest because KRAS mutations are common in early stages of colorectal cancer and are considered to be one of the first genetic mutations in the course of tumor development.19 It is therefore essential that future experiments significantly increase the sample size in order to reinforce the validity of our results. This evidence concerns the gene KRAS and colorectal cancer.